Related Experiment Video
Updated: Sep 8, 2025

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD
Connie N Hess1,2, Iris Baumgartner3, Sonia S Anand4
1Division of Cardiology, Department of Medicine University of Colorado School of Medicine Aurora CO.
Women with peripheral artery disease (PAD) undergoing lower extremity revascularization (LER) had similar primary outcomes as men, but a trend for higher revascularization risk. Rivaroxaban effects were consistent across sexes, though women were more likely to stop treatment.
Area of Science:
- Vascular Surgery
- Cardiology
- Pharmacology
Background:
- Peripheral artery disease (PAD) disproportionately affects women, yet sex-based outcomes post-lower extremity revascularization (LER) remain understudied.
- The efficacy and safety of rivaroxaban in relation to sex following LER require further investigation.
Purpose of the Study:
- To analyze sex-based differences in outcomes after LER for symptomatic PAD.
- To evaluate the consistent effects of rivaroxaban across sexes in patients undergoing LER.
Main Methods:
- Analysis of data from the VOYAGER PAD trial, including 6564 patients undergoing LER.
- Cox proportional hazards models were used to assess outcomes and treatment effects by sex.
- Primary efficacy outcome: composite of cardiovascular and limb events. Primary safety outcome: Thrombolysis in Myocardial Infarction major bleeding.
Main Results:
- Women (26%) had similar risk for the primary efficacy outcome compared to men but showed a trend towards higher risk of unplanned index limb revascularization (HR 1.18).
- Rivaroxaban demonstrated consistent effects on efficacy, limb revascularization, and bleeding outcomes irrespective of sex (P-interaction > 0.20 for all).
- Women were more likely to discontinue study treatment compared to men (HR 1.13).
Conclusions:
- While women and men had similar primary efficacy outcomes post-LER, women exhibited a trend for increased risk of unplanned revascularization.
- Rivaroxaban's therapeutic benefits were consistent across sexes, but adherence may be a concern for female patients.
- Further research is needed to understand sex-based outcomes and improve treatment adherence in PAD patients undergoing LER.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Peripheral Artery Disease IV: Nursing Management

